Saxagliptin/Metformin fixed-dose combination tablet
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Saxagliptin/Metformin fixed-dose combination tablet, covering 2012-02-08 to 2012-02-08. Get the full timeline:
Most recent: Clinical Trial Update: Bioequivalence Study of Fixed Dose Combination of 2.5 mg Saxagliptin/850 mg Metformin Tablet Relative to 2.5 mg Onglyza and 850 mg Glucophage Tablets Co-Administered [Phase 1]